A retrospective study of 158 hemodialysis patients found that a higher preoperative stress hyperglycemia ratio was ...
Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...
The researchers found that a physiologically mature arteriovenous fistula (blood flow ≥500 mL/minute and a target vein internal diameter ≥4 mm) was obtained in 98 percent of cases. In 95 percent of ...
Neither omega-3 fatty acids from fish nor aspirin prevented failure of arteriovenous fistulae (AVFs) in patients receiving hemodialysis, according to results of a new study published online January 3 ...
Please provide your email address to receive an email when new articles are posted on . Researchers from Canada found placement of an arteriovenous fistula slowed decline in kidney function for ...
Merit Medical Systems, Inc. announced results from the arteriovenous fistula (AVF) cohort of the WRAP Global registry, which i ...
More than 600,000 people in the United States have end-stage kidney disease, and about 450,000 are kept alive through chronic hemodialysis to remove waste products from their blood. This requires ...
The first North American patients were treated by a multidisciplinary clinical team led by Dr. Mohamad Hussain and Dr. Dirk Hentschel. The AMPLIFI-1 Trial is designed to evaluate the safety and ...
Zacks Investment Research on MSN
Merit Medical reports strong real-world data for WRAPSODY device
Merit Medical Systems MMSI recently announced positive real-world clinical data from the arteriovenous fistula (AVF) cohort of its WRAPSODY Global registry. The WRAPSODY Cell-Impermeable ...
An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results